Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
150 |
|
| Actual shortage: | 4 (3%) | |
| Anticipated shortage: | 3 (2%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (93%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-08-15 | 2018-10-18 | 58228 |
| ILEVRO | 0.3% | SUSPENSION | Resolved | 2018-08-24 | 2018-12-13 | 58947 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2018-08-28 | 2018-10-04 | 59387 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-08-28 | 2019-02-05 | 59391 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2018-09-28 | 2018-10-17 | 62545 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2018-10-17 | 2018-12-18 | 64629 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2018-10-23 | 2018-11-07 | 65471 |
| MAXITROL | 1MG 6000UNIT 3.5MG | SUSPENSION | Resolved | 2018-11-23 | 2019-02-05 | 67487 |
| BETOPTIC S | .25% | SUSPENSION | Resolved | 2018-11-23 | 2019-01-03 | 67490 |
| TOBREX | .3% | SOLUTION | Resolved | 2018-12-11 | 2019-02-05 | 69257 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2018-12-19 | 2019-02-02 | 70039 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Avoided shortage | 2019-01-08 | 2019-04-29 | 71606 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-01-08 | 2019-01-28 | 71609 |
| VIGAMOX | 0.5% | SOLUTION | Resolved | 2019-01-16 | 2019-03-26 | 72680 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-01-25 | 2019-03-13 | 73545 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-02-11 | 2019-03-09 | 75340 |
| CILOXAN | 0.3% | OINTMENT | Resolved | 2019-02-11 | 2019-04-29 | 75343 |
| ZOFRAN | 4MG | SOLUTION | Resolved | 2019-02-15 | 2019-04-09 | 75937 |
| TRILEPTAL 300 MG | 300MG | TABLET | Resolved | 2019-02-25 | 2019-03-07 | 76783 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-03-11 | 2019-04-06 | 78252 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |